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The stress-activated protein kinase pathway mediates cell death
following injury induced by cis-platinum, UV irradiation or heat
Brent W. Zanke*†, Kimberly Boudreau†, Elizabeth Rubie†, Elaine Winnett†, Lee
Anne Tibbles†, Leonard Zon‡, John Kyriakis§, Fei-Fei Liu¶† and James R. Woodgett†
Background: Stimuli that stress cells, including inflammatory cytokines, ultra-
violet irradiation, DNA-damaging chemotherapeutic drugs and heat shock,
stimulate a recently identified cytoplasmic signaling system that is structurally
related to the mitogen-activated protein kinase pathway. This pathway consists
of a cascade of protein kinases including stress-activated protein kinase (SAPK),
also termed Jun N-terminal kinase (JNK), and two kinases that activate it, MEKK
and SEK/MKK4. Despite rapid progress in delineating the components of this
pathway, the cellular consequence of its activation remains to be defined. 
Results: We have screened cells for defects in SAPK signaling and identified a
cell line, previously characterized for its thermotolerance properties, as being
more refractive to SAPK activation induced by heat stress than its
thermosensitive parental line. Stable expression of dominant inhibiting SEK
mutants in thermosensitive parental cells specifically and effectively blocked
SAPK activation after heat shock. These lines also became markedly resistant to
the cytocidal effects of thermal stress, confirming the phenotype of the
thermotolerant line. These cell lines defective in SAPK activation were also
resistant to the lethal effects of the DNA-damaging drug cis-platinum. 
Conclusions: Experimentally induced stable blockade of SAPK activation in cells
with normal thermosensitivity is sufficient to confer resistance to cell death
induced by diverse stimuli including heat and the chemotherapeutic agent cis-
platinum. These results suggest that activation of the SAPK pathway by diverse
cell stressors plays a critical part in mediating the toxicity of these treatments
and inducing cell death. SAPK activation in this context could broadly influence
cellular response to stress, modulate apoptosis during development or determine
the clinical response of tumor cells to cytotoxic therapies.
Background
Whereas mitogens and growth factors lead to activation of
protein kinase cascades resulting in activation of ERK
(extracellular signal-regulated kinase) family MAP
(mitogen-activated protein) kinases [1], many forms of cel-
lular stress lead to activation of two related signaling path-
ways. These center on two MAP kinase homologs,
stress-activated protein kinase (SAPK), also known as Jun
N-terminal kinase (JNK), and p38/CSBP/RK, which is the
mammalian counterpart of yeast HOG1. Targets of
SAPK/JNK include the c-Jun and JunD components of
the AP-1 transcription factor, which becomes activated
after cell toxin exposure [2–8].
SAPKs were first isolated as a MAPK protein kinase
activity induced by cycloheximide [9,10]. Molecular
cloning revealed that the SAPKs comprise a family of at
least eight isoforms derived by differential splicing from
three or more genes, to generate proteins of 54 kDa and
46 kDa. The JNK1 and JNK2 protein kinases are a
subset of these and correspond to p46 SAPKg and
p54SAPKaII, respectively [3]. In addition, a brain-spe-
cific isoform termed p493F12 has been isolated, the
sequence of which is similar to p54SAPKb [11]. Like the
archetypal ERKs, the SAPK/JNKs require phosphoryla-
tion on a closely spaced tyrosine and threonine within
subdomain VIII of the kinase domain for activation
[10,12]. However, members of this family of proteins
contain a proline between the phosphorylation sites,
unlike the ERK family of MAP kinases which all contain
glutamic acid in this position. This difference probably
accounts for the fact that most of the agonists for the two
pathways fall into two distinct groups. Mitogens, often
acting via Ras, are potent ERK activators but activate
SAPK/JNK poorly. In contrast, stress stimuli such as the
inflammatory cytokine TNF-a, interleukin-1, aniso-
mycin, cycloheximide, heat shock, ultraviolet (UV),
ischemia/reperfusion and sodium arsenite are powerful
inducers of SAPK/JNK but induce ERKs relatively
weakly [2,4,5,12]. 
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The differential pattern of activation suggests that the
SAPK/JNK and ERK family kinases are part of distinct sig-
naling cascades. The cloning of upstream components of
the SAPK/JNK pathway has substantiated this expectation.
Whereas the ERK kinases are activated by MEK (dual-
specificity ERK kinase) and by its upstream regulators Raf
and Ras [13–15], SAPKs are activated by a cascade involv-
ing highly homologous, though distinct, kinases. SAPK is
activated by dual phosphorylation by the MEK homolog
SAPK and ERK kinase-1 (SEK1), which has also been
termed MKK4, and JNKK (JNK kinase) [12,16,17]. SEK1
co-precipitates with SAPKs when co-expressed in cells and
is itself activated by the same agonists as SAPK [12]. SEK1
is itself dependent on phosphorylation for activity and is a
direct target of MEKK, a protein serine kinase initially
thought to regulate MEK [1,18]. 
A third MAP kinase-related pathway has been elucidated
in mammalian cells. This pathway is related to a pathway
induced by hyperosmolarity in budding yeast that acti-
vates a MAP kinase relative termed HOG1. The mam-
malian counterpart of this gene is variously termed p38,
CSBP and RK, and is activated by many of the stress
stimuli that result in SAPK activation [19,20]. Although
p38HOG can be phosphorylated by SEK1/MKK4 in vitro
[17], the p38HOG kinase activation site, TGY (threonine–
glycine–tyrosine), is distinct from the SAPK site of dual
phosphorylation (TPY), suggesting that SAPK and p38HOG
are the physiological substrates for different kinases.
Moreover, although the spectrum of SAPK agonists over-
laps that of p38HOG, there are several distinctions. For
example, SAPK is specifically activated by reperfusion fol-
lowing an ischemic episode [2], but p38HOG is activated by
the initial ischemia (P. Sugden, personal communication).
Furthermore, p38HOG activity is unchanged in cells trans-
fected with constitutively active MEKK, a known activa-
tor of SEK1 and SAPK (our unpublished observations).
These data imply that the pathways resulting in the acti-
vation of p38HOG and SAPK are distinct and that SEK1 is
not the physiological activator of p38HOG. A distinct
protein kinase termed MKK3 is more likely to be the
physiological regulator p38HOG [16]. Although SEK1 has
low overall amino-acid identity to MEK, the two proteins
are related in the region between kinase subdomains VII
and VIII [12,15,17,18]. Alignment of the SEK1 and MEK
sequences in this region shows SEK1 Ser254 and Thr258
to be coincident with the two Raf-targeted residues in
MEK, suggesting they, too, are sites of activating phos-
phorylation. To test this we mutated these two residues to
alanine and leucine, respectively, to generate a mutant
termed SEK-AL. When expressed in COS cells, this
mutant acts as a transdominant negative and inhibits
SAPK activation by all the agonists tested [12,18]. The
mutant does not significantly interfere with p38HOG or
ERK activation and is thus a potentially useful tool to
specifically disrupt SAPK signaling.
Despite rapid progress in the elucidation of the structural
elements of the SAPK/JNK pathway, the physiological
consequences of its stimulation by stress agents remain to
be defined. Sustained activation of SAPKs via inducible
expression of a constitutively active form of MEKK results
in marked growth arrest in fibroblasts [18]. This may indi-
cate the SAPK pathway has a protective role, perhaps
allowing cells to repair damage, or a destructive one, if
activation triggers apoptosis as has been suggested
recently [21]. To investigate the consequences of SAPK
stimulation in intact cells, we assessed SAPK activation in
a series of cell lines previously shown to have stable resis-
tance to the toxic effects of various stresses. For thermal
sensitivity, we used the RIF-1 mouse fibroblast cell line
[22] and its derivative TR-4, which has been selected after
repeated episodes of heat shock [23,24]. These cell lines
have been used extensively in the investigation of mecha-
nisms of thermotolerance as TR-4 variant cells have
greater relative thermoresistance than other reported
lines, yet have morphological and growth characteristics
which are similar to parental RIF-1 cells [23]. Although
TR-4 fibroblasts express increased levels of low and high
molecular weight heat-shock proteins, which induce
thermotolerance in many cell systems [24], the molecular
mechanism of thermotolerance in this line has not yet
been elucidated.
Results
Examination of SAPK activation by heat shock in
thermotolerant TR-4 cells
To confirm the thermotolerant nature of TR-4 cells,
clonogenic survival was assessed and compared with that
of parental RIF-1 cells after timed incubation at 43 °C. As
has been reported previously [24], we demonstrated that
clonogenic survival of RIF-1 cells declines by 90 % after
90 minutes at 43 °C, whereas TR-4 cells exhibit minimal
reduction in clonogenic cells after similar exposures (Fig.
1a). Before heat shock, the growth rates of both cell types
and their appearance under the light microscope were
similar (data not shown). 
Western-blot analysis of two equivalent amounts of
protein from cell lysates derived from the two cell lines
were performed using rabbit antiserum that crossreacted
with the three SAPK isoforms. Both cell lines were found
to have similar levels of expression of both the 46 kDa and
54 kDa splice forms of SAPK a and g (Fig. 1b). However,
SAPK enzymatic activity after heat shock in each of the
two lines was markedly different. Equivalent samples from
each line were exposed to either thermal stress at 43 °C for
30 minutes or UV irradiation of 50 J m–2. SAPK was
immunoprecipitated and its enzymatic activity toward
c-Jun/GST fusion protein assessed. Whereas RIF-1 and
TR-4 cells showed equivalent activation of SAPK after UV
irradiation, SAPK activation was markedly impaired after
heat shock of the thermoresistant TR-4 cells (Fig. 1c).
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As TR-4 cells show both thermotolerance and impaired
activation of SAPK after heat shock, but normal activation
of SAPK after UV irradiation, we investigated TR-4 cell
survival after UV exposure. Equivalent numbers of each
cell type were irradiated to various energy levels. Cell via-
bility was measured 24 hours after exposure by assessing
the conversion of the chromogenic substrate 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) by metabolically active cells in each well. Despite
the resistance to heat shock previously demonstrated in
the TR-4 cells, they did not show greater resistance to UV
exposure than the control RIF-1 cells (Fig. 1d). Under
these assay conditions, TR-4 cells are more sensitive to
the toxic effects of UV than RIF-1 cells.
Generation of cells demonstrating inhibition of stress-
induced SAPK activation
The level of SAPK activation after heat shock or UV irradi-
ation of RIF-1 and TR-4 cells correlates with the level of
cell death after each of these exposures. To establish a
causal link between impairment of SAPK activation and
resistance to death after cell stress, we introduced SEK-AL
cDNA (encoding SEK1, the form of the SAPK activator
that acts as a dominant inhibitor) tagged with a hemagglu-
tinin epitope, into parental RIF-1 cells by gene transfer.
We derived control transfected RIF-1 cells, RIF-1(V),
which had been transfected with the plasmid pcDNA3
alone. Numerous stable transfectants which expressed
tagged SEK-AL were identified by immunoprecipitation
followed by western-blot analysis using the commercial
antibody, 12CA5, which recognizes the hemagglutinin tag.
The highest expressing clones, RIF/SEK-AL18 and
RIF/SEK-AL19, were selected for further study (Fig. 2a).
Equal numbers of each cell type were plated at low density
and logarithmic growth rates determined by counting
trypsinized replicate samples. RIF-1(V), RIF/SEK-AL18
and RIF/SEK-AL19 cells were shown to have similar
growth rates (Fig. 2b). 
The activity of immunoprecipitated SAPK in RIF-1(V),
RIF/SEK-AL18 and RIF/SEK-AL19 cells was compared
before and after heat shock. As predicted, the SEK-AL-
expressing RIF-1 variants demonstrated marked inhibition
of SAPK activation in response to heat, similar to that
observed in the unmanipulated TR-4 cell line (Fig. 3a). To
examine the specificity of SAPK inhibition by SEK-AL
expression in these cell lines, the activities of the other
known MAPK mammalian homologs were assessed follow-
ing stimulation. The enzymatic activity of immunoprecipi-
tated p42/p44ERK toward myelin basic protein (MBP)
kinase was evaluated after cell stimulation by the phorbol
ester PMA (Fig. 3b). Similar stimulation by PMA was seen
in RIF-1(V), RIF/SEK-AL18 and RIF/SEK-AL19 cells.
Similarly, p38HOG kinase was immunoprecipitated from
these cell lines before and after stimulation with 400 mM
sorbitol for 30 minutes. Both the RIF-1(V) and the SEK-
AL-expressing lines demonstrated unimpaired activation of
p38HOG measured both by direct assessment of enzymatic
Figure1
TR-4 cells have impaired activation of SAPK in
response to heat shock. (a) Clonogenic
survival of RIF-1 and TR-4 cells after heat
shock. Each cell type was heat shocked in
triplicate as described. Results are expressed
as a percentage of colony numbers produced
from samples of unshocked cells. Error bars
represent standard error. (b) Analysis of
SAPK content by western-blot analysis of
whole cell lysates from RIF-1 and TR-4 cells.
Cell samples were prepared as described.
Lanes 1 and 2 contain 40 mg and 80 mg of
lysate protein, respectively. (c) c-Jun kinase
assay of SAPK immunoprecipitated from
RIF-1 or TR-4 cells stimulated by UV
irradiation or by heat shock. The arrow marks
the migration of phosphorylated GST c-Jun.
(d) Survival of RIF-1 and TR-4 cells after UV
irradiation. Cells (103 per well of a 96-well
tissue culture dish) were exposed to UV-C
irradiation in doses as indicated. Conversion
of MTT was assessed 24 h after exposure as
described in Materials and methods. Results
are expressed as a ratio of OD570 in irradiated
wells to untreated wells with standard errors. 
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activity of immunoprecipitated enzyme and by anti-
p38HOG western-blot analysis of anti-phosphotyrosine
immunoprecipitates from heat-stimulated cells (Fig. 3c,d).
Analysis of survival of SEK-AL-expressing cells after heat
shock
To evaluate the ability of the SEK-AL-transfected cells to
survive heat stress, two independent assay systems were
used: MTT conversion and clonogenic survival.
To assess immediate reduction in cell viability after heat
shock, metabolism of MTT by equivalent cell numbers of
each cell type was assessed 24 hours after timed exposures
to 43 °C. Cell viability was expressed as a ratio of MTT
conversion (measured as the optic density at 570 nm) in
wells containing treated cells to that in wells containing
equivalent numbers of unexposed cells. Both SEK-AL-
expressing cell lines were relatively resistant to the toxic
effects of heat, with MTT conversion at about 70 % of the
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Figure 3
SAPK activation in response to heat shock is
impaired by SEK-AL expression. (a) SAPK
activity in RIF-1(V), TR-4 and in the two SEK-
AL-expressing RIF-1 variant cell lines after
heat shock. Cells were heat shocked (HS) as
described then lysed. SAPK was
immunoprecipitated and analyzed by in vitro
c-Jun kinase assay as described in Materials
and methods. The arrow marks the migration
of GST c-Jun. Numbers below each panel
represent a densitometric comparison of
lanes within each figure derived using a
phosphoimager. (b) Activity of p44/p42 ERK
kinase from each cell type was assessed in
unstimulated samples (C) or following
stimulation with PMA (P). Samples were
analyzed as described in Materials and
methods. The arrow marks the migration of
MBP. (c) p38HOG activity in RIF-1(V) cells
and the SEK-AL-expressing derivatives. Cell
samples were incubated in 400 mM sorbitol
(S) and tissue culture medium or in medium
alone (C) as described in Materials and
methods. p38HOG was assayed as described.
The arrow marks the migration of MBP.  (d)
Anti-p38HOG western- blot analysis of anti-
phosphotyrosine immunoprecipitates derived
from control transfected RIF-1 cells and from
the two SEK-AL-expressing derivative lines.
The arrow marks the migration of p38HOG.
Cells were unstimulated (C) or stimulated (S)
as described in (c).
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Figure 2
Expression of SEK-AL in RIF-1 fibroblasts. (a)
Demonstration of expression of SEK-AL in two
stable cell lines by immunoprecipitation of
hemagglutinin-tagged SEK-AL followed by
western blot analysis using the monoclonal
antibody 12CA5. Comparison with vector-
transfected RIF-1, RIF-1(V), is provided.
Immunoglobulin heavy chain (HC) and light
chain (LC) are indicated. (b) Growth rates of
RIF-1(V), RIF/SEK-AL 18 and RIF/SEK-AL 19.
Replicate samples of 1 x 104 cells were
plated into 10 cm tissue culture plates. At
timed intervals cells in individual plates were
trypsinized and counted using a
hemocytometer. Results are expressed as a
fold increase over the cell number at time 0,
which was measured 4 h after cell plating, a
point when all cells had become adherent.
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baseline rate, whereas RIF-1(V) cells converted MTT at
40 % of the baseline rate (Fig. 4a).
Clonogenic survival was measured in RIF-1(V), RIF/SEK-
AL18 and RIF/SEK-AL19 cells after timed exposures to
43 °C. Equivalent numbers of cells were heat-shocked
and plated at low density. Numbers of colonies appearing
seven days after heat shock were assessed by methanol
fixation and methylene blue staining, and were expressed
as a percentage of colonies appearing from samples of non-
heat-shocked cells of each type. Whereas RIF-1(V) cells
demonstrated 90 % reduction in clonogenicity after
90 minutes at 43 °C, both SEK-AL-expressing lines
demonstrated less than 30 % reduction after similar treat-
ment (Fig. 4b).
Analysis of survival of SEK-AL-expressing cells after
exposure to cis-platinum
Cis-platinum is a heavy metal compound known to cause
DNA cross-linking and apoptosis of exposed cells [25,26].
This agent has recently been shown to cause SAPK stimu-
lation in cells [27], and is an important drug used in the
clinical management of a variety of human malignancies. As
we have shown that expression of SEK-AL in RIF-1 fibrob-
lasts confers resistance to heat, we studied the ability of
SAPK inhibition in this system to affect cell sensitivity to
cis-platinum. The clonogenic survival of RIF-1(V),
RIF/SEK-AL18 and RIF/SEK-AL19 cells was assessed
following continuous exposure to cis-platinum. Both SEK-
AL-expressing cell lines had increased clonogenic survival
compared to RIF-1(V) cells. Clonogenicity of RIF-1(V)
cells was reduced by approximately 85 % by incubation
with 0.125 mg ml–1 cis-platinum, whereas each of the SEK-
AL-transfected cell lines displayed reductions of only about
30 % (Fig. 5a). MTT conversion following a two-hour expo-
sure to various doses of cis-platinum was measured for each
of the cell lines, and viability was expressed as a ratio of
optical density at 570 nM in treated versus untreated cells.
RIF/SEK-AL 18 and RIF/SEK-AL 19 were more resistant
to cis-platinum than were RIF-1(V) cells. TR-4 cells were
also relatively resistant to cis-platinum (Fig. 5b). To confirm
that SEK-AL expression affects the ability of cis-platinum
to activate SAPK, enzymatic activities were measured in
each cell line after stimulation with 10 mg ml–1 cis-platinum
for two hours. SAPK was inducible after this exposure in
RIF-1(V) cells, but was inhibited in both the SEK-AL-
expressing lines and the TR-4 cell line (Fig. 5c).
Discussion
Correlation of stress-induced SAPK activation and cell
survival in RIF-1 and TR-4 cells
The TR-4 cell line, derived from RIF-1 fibroblasts [22],
has a stable thermotolerant phenotype but has normal cell
morphology and growth characteristics [24]. Although the
TR-4 line has increased levels of heat-shock proteins
which can by themselves induce stable thermotolerance,
the genetic basis for its remarkable phenotype has not yet
been elucidated.
SAPK activity is induced in response to thermal stress.
While studying the relationship between cell death and
the activation of SAPKs by various cell stressors, we
observed a block in SAPK activation after thermal shock in
TR-4 cells. However, SAPK activation after other stressors
such as UV irradiation and anisomycin was preserved. This
suggests, in general, that heat shock induces SAPK activa-
tion through pathways that are at least partially distinct
from those induced by UV irradiation and anisomycin. A
similar conclusion has been advanced by Adler et al. [28],
who demonstrated that heat stress may cause SAPK activa-
tion through signaling pathways that are dependent, in
part, on intact mitochondrial function, whereas UV may
initiate a SAPK activation cascade from the cell membrane,
possibly through the generation of reactive oxygen inter-
mediates. Our experiments do not elucidate the specific
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Figure 4
Survival of SEK-AL-expressing cells after heat shock. (a) Survival of
RIF-1(V) cells and SEK-AL-expressing derivatives after heat shock.
Cells (104 per well of 96-well plates) were heat shocked by incubation
at 43 °C as described in Materials and methods. Conversion of MTT
was assessed 24 h after heat shock and is expressed as a ratio of
OD570 measurements of treated to untreated wells. (b) Survival of
RIF-1(V) cells and SEK-AL derivatives after heat shock, assessed by
clonogenic survival. 
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mechanism of heat-shock induction of SAPK that is defec-
tive in TR-4 cells, though we conclude it is proximal to a
common pathway of SAPK activation involving SEK-1,
likely stimulated by all stress agents. Heat-shock-induced
SEK-1 phosphorylation in TR-4 cells was reduced com-
pared to that observed in RIF-1 cells as identified by
western-blot analysis of total protein using antibodies
specific for the phosphorylated form (data not shown).
TR-4 cells are resistant to the cytocidal effects of both heat
shock and the DNA-damaging agent cis-platinum. As we
have shown, this resistance to cell death coincides with the
reduced activation of SAPK by these agents. By contrast,
UV irradiation, which efficiently kills TR-4 cells, induces
normal SAPK activation. The relationship between
absence of SAPK activation after stress stimuli and resis-
tance to cell death suggests SAPK may be a mediator of
cell death. SAPK may also function to repair sub-lethal
stress-induced damage, but our data do not address this.
Resistance to cell death and apoptosis after inhibition of
SAPK activation
To test the hypothesis that SAPK activation mediates cell
death after stress-induced injury, we generated stable cell
lines expressing a dominant inhibitor of SAPK activation,
SEK-AL. This mutant has the non-phosphorylatable
residues alanine and leucine at positions 254 and 258
instead of the naturally occurring serine and threonine
residues which are required to be phosphorylated for SEK
activation. We have shown previously that transient expres-
sion of SEK-AL impairs activation of SAPK after stimula-
tion with various cell stressors [18]. In the present study,
we describe two RIF-1 cell lines that express SEK-AL,
RIF/SEK-AL18 and RIF/SEK-AL19, in which the activa-
tion of SAPK after stimulation by heat and cis-platinum is
impaired. Despite this impairment, the other known mam-
malian MAP kinases p42/44ERK and p38HOG are activated
normally in SEK-AL-expressing cells, suggesting that the
biochemical blockade we have induced is specific for SAPK
activation. As a result of this biochemical blockade of SAPK
activation, both of these derived lines are resistant to the
toxic effects of heat or cis-platinum. This observation is
consistent with a role for SAPK as a trigger of cell death
after critical damage to cell macromolecules. This conclu-
sion is supported by work using dominant negative mutants
of c-Jun which impair cell death following treatment with
TNF-a and UV irradiation [29].
Both heat and cis-platinum are known to cause cell death by
programmed cell death, or apoptosis. Although each induce
specific and distinct structural damage, both result in a
similar cell phenotype characterized by hypodiploid nuclear
DNA content, cytoplasmic membrane blebbing, and cyto-
plasmic and nuclear compaction [26]. Though not specifi-
cally addressed here, SAPK activation may result in the
activation of apoptotic pathways which become blocked in
cells expressing the dominant inhibitor SEK-AL. These
data are consistent with our previous demonstration that
artificial induction of SAPK activation through the induced
expression of MEKK, the physiological activator of SEK-1,
results in arrest of cell growth and the development of char-
acteristics of apoptosis visible under the light microscope
[6]. Recently, Johnson et al. [30] concluded that partial
SAPK inhibition did not ablate MEKK-induced death, sug-
gesting that other MEKK-regulated pathways may also con-
tribute to apoptosis. Indeed, although cell lines expressing
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Figure 5
Survival of SEK-AL-expressing cells after cis-
platinum exposure. (a) Survival of RIF-1(V)
cells and the SEK-AL-expressing derivatives
after exposure to cis-platinum. Clonogenic
survival as a percentage of that in untreated
cell samples from three individual experiments
is expressed with standard error calculations.
(b) Survival of TR-4, RIF-1(V) and the SEK-
AL-expressing RIF-1 derivatives 24 h after a
2 h exposure to cis-platinum. MTT conversion
in each well is expressed as a ratio of OD570
in treated to untreated wells. Standard errors
derived from three independent experiments
are indicated. (c) SAPK activity in the four cell
lines after no stimulation (C) or after exposure
to 10 mM cis-platinum (P) for 2 h. Activity was
measured as described in Materials and
methods. GST cJun migration is indicated by
the arrowhead. Numbers below the panel
represent comparative densitometric analysis
of each lane.
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SEK-AL are 3–5 times more resistant to various stressors
than parental lines, SAPK inhibition does not provide total
protection from apoptotic cell death (Figs 4,5). 
Apoptosis in mammalian cells is understood to involve the
control of lethal proteases and endonucleases by balanced
‘death stimuli’ and ‘survival signals’ [31]. Diverse stimuli
such as the withdrawal of growth factors, activation of cyto-
plasmic receptors containing the ‘death domain’, or DNA
damage initiate signaling cascades that ultimately result in
protease activation, which results in the apoptotic pheno-
type. These cascades are thought to be integrated with anti-
apoptotic signaling pathways initiated by positive trophic
influences such as growth factors, so that there is balanced
regulation of common ‘effector’ molecules. We have
demonstrated that SAPK activation is associated with cell
death after heat stress or treatment with the drug cis-plat-
inum, two stresses known to result in apoptosis. As inhibi-
tion of SAPK activation protects cells from cell death, it
may normally regulate downstream signaling events leading
to the induction of apoptotic effectors. Data have been
reported by Xia et al. [21] showing that differentiated
neuroepithelial PC12 cells transiently transfected with
dominant inhibiting MKK4 (SEK1) escape apoptosis after
serum withdrawal, which is consistent with this hypothesis. 
Although the three MAPK signaling pathways involving the
ERK, SAPK and p38HOG kinases share structural similarity,
the outcomes of activation seem to be quite different (Fig.
6). ERK stimulation by mitogenic and trophic agents results
in cell division and differentiation. Activation is seen during
normal tissue growth and pathologically as a consequence of
cell transformation, whereas growth arrest and cell death is
seen after SAPK activation by physical and biological stress.
Whereas regulation of the ERK signaling cascade may allow
control of unregulated cell growth in many disease
processes, regulation of SAPK activation may allow control
of processes characterized by enhanced or attenuated cell
death. As one example, we provide evidence that
chemotherapeutic drug-resistance in our experimental
system may be regulated by SAPK activation, an observa-
tion which may have relevance to cancer chemotherapy.
Further study of SAPK regulation will provide more insights
into the regulation of normal and pathological cell death.  
Materials and Methods
Antibodies and reagents
SAPK antiserum was raised in rabbits against the p54 aI form expressed
in bacteria as a GST fusion protein. p38HOG antiserum was similarly
derived. Anti-p42/p44ERK was purchased from Upstate Biotechnology.
PY20 anti-phosphotyrosine antibody was purchased from Transduction
labs. RIF-1 and TR-4 cells were a gift of G. Hahn. NP40, phorbol 12-13
myristic acid (PMA), anisomycin, myelin basic protein and miscellaneous
chemicals were purchased from Sigma. Cis-platinum was purchased
from Bristol. All tissue culture was performed in Dulbecco’s Modified
Eagle Medium (DMEM, Gibco), containing 10% Cool Calf Serum
(Gibco). Anti-phospho SEK-1 antibodies were purchased from New
England Biolabs (Beverly, MA). 
Western analysis
106 cells were lysed on ice for 1 h in 100 ml 0.1 % NP40, 125 mM NaCl,
25 mM Tris, pH 7.2 containing the protease inhibitors leupeptin 1 mg ml–1,
aprotinin 1 mg ml–1 and 1 mM phenylmethylsulfonyl fluoride (all Sigma), fol-
lowed by centrifugation. Protein concentrations were determined by Bio-
Rad assay. Lysates were boiled in SDS loading buffer as described [32]
and analyzed on a 10 % acrylamide denaturing gel followed by semi-dry
transfer. 
Anti-phosphotyrosine immunoprecipitation
106 cells were lysed on ice for 1 h in 500 ml 0.1 % NP40, 125 mM NaCl,
25 mM Tris, pH 7.2 with the protease inhibitors leupeptin 1 mg ml–1, apro-
tinin 1 mg ml–1 and 1 mM phenylmethylsulfonyl fluoride, followed by cen-
trifugation. Phosphatase activity was inhibited by 5 mM sodium
orthovanadate and 50 mM dibasic sodium pyrophosphate (Sigma).
Lysates were incubated on ice with 5 ml PY20 antibody for 2 h followed
by incubation with 50 ml of Sepharose protein A beads (Pharmacia) at
4 °C with agitation. Precipitates were washed four times with 1 ml of
ice-cold lysis buffer.
Generation of SEK-AL-expressing cell lines
SEK, which was mutated to code alanine and leucine at positions 220 and
224 as described [18], was cloned in frame downstream of the sequence
ATGGCTTACCCATACGATGTTCCAGAT defining the influenza hemag-
glutinin epitope tag (HA) MAYPYDVPD and was cloned into the pcDNA3
plasmid (Invitrogen). Transfections were performed in RIF-1 cells using
calcium phosphate as described [32]. Cells were selected with
500 mg ml–1 G418 (Gibco) in DMEM containing 10 % calf serum and ana-
lyzed for HA/SEK-AL expression by immunoprecipitation with the mono-
clonal antibody 12CA5 (Bohringer Mannheim) followed by immunoblotting
of precipitates with the same antibody. Control samples were derived from
RIF-1 cells transfected with empty pcDNA3 vector, RIF-1(V), which were
similarly selected for G418 resistance.
Heat shock of cultured cells
Clonogenic survival: Both RIF-1, TR-4 and derivative cell lines were heat-
shocked as monolayers plated in 25 cm2 sealed flasks at a density of 104
cells cm–2 which were immersed in a temperature-controlled water bath
(Grant Instruments Ltd, Cambridge, England) calibrated to ± 0.01 °C.
Cells were immersed at 43.00 °C for the indicated times. Equilibration
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Figure 6
Consequences of activation of the MAPK pathways. Activation of the
ERK family of MAPKs through MEK and Raf results in cell mitogenesis or
cell differentiation. This pathway contains many known oncogenes such
as ras and has been implicated in cell transformation. In addition to its
mitogenic role, activation in cell differentiation has been demonstrated in
systems such as PC12 cells where it causes primitive neuroectodermal
cells to undergo neuronal differentiation. Inhibition of SAPK activation in
response to noxious stimuli prevents cell death, implying a role for SAPK
as a mediator of growth arrest and cell elimination. As yet the
physiological role of the p38HOG MAPK is uncertain.
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from 37.00 °C to 43.00 °C is attained within 2 min. After heating, cells
were trypsinized, counted and plated in a-MEM plus 10 % FCS. Cells
were then incubated at 37 °C in a humidified atmosphere with 5 % CO2
for 7–10 days and stained with methylene blue in 50 % ethanol to visual-
ize colonies. Each set of experiments was repeated at least three times.
MTT assay: 103 cells per well were plated in 96-well tissue culture plates.
Each plate contained five occupied wells per cell type and was used to
generate a single survival time point for each cell type. Individual plates
were immersed in the temperature-controlled water bath as described
above for the indicated times. After heat exposure, fresh medium equili-
brated to 37 °C was placed in each well.
Cis-platinum exposure of cultured cells
Clonogenic survival: 105 cells of each type were plated into 10 cm tissue
culture dishes containing various doses of cis-platinum. After seven days
colonies appearing were fixed with 80 % methanol containing 0.25 %
methylene blue and counted if macroscopically visible. MTT assay: 103 cells
per well were plated in 96-well tissue culture plates and incubated with
various doses of cis-platinum for 24 h. Cells were washed and incubated
with fresh medium for an additional 24 h after drug exposure. At that time
point, MTT conversion was assessed as described below. 
Cell stimulation and in vitro kinase assays
107 cells per sample were heated to either 43.00 °C for 30 min as
described above, exposed to either anisomycin at a concentration of
500 mg ml–1 for 30 min, cis-platinum at 50 mM for 1 h, PMA at
250 ng ml–1 or irradiated using a DNA Stratalinker (Stratagene) to a dose
of 50 J m–2. SAPK was immunoprecipitated and incubated with GST c-
Jun with [32P]g-ATP as described [12]. Immunoprecipitated p38HOG
kinase or p44/p42ERK kinase were similarly incubated with 1 mg of the
substrate MBP as indicated. Products were analyzed by phosphoimager
and ImageQuant software (Molecular Dynamics) after poly acrylamide gel
electrophoresis.
MTT cell viability assay
MTT conversion as a measure of cell viability was performed as described
[33]. MTT was dissolved at a concentration of 5 mg ml–1 in sterile PBS and
filter sterilized. MTT stock solution (25 ml) was added to each well to be
analyzed and incubated for 2 h at 37 °C at which point 100ml of extraction
buffer consisting of 20 % w/v SDS and 50 % dimethyl formamide, pH 4.7,
was added. Cells were incubated for an additional 24 h. Optic densities
(570 nm) were then measured using a Titre-Tech 96-well multiscanner
using identically treated wells containing tissue culture medium alone as the
blank. Sample results are expressed as a ratio of ODs from untreated wells.
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